The Atlantic Rift: FDA Allows Peptide Compounding—Where Does the UK Stand?
The world of peptide research is moving away from regulatory ambiguity. For years, the landscape has been defined by "Research Use Only" (RUO) labels and the complexities of personalised medicine. However, a seismic announcement from the US Food and Drug Administration (FDA) has sent shockwav…
